The Centers for Medicare & Medicaid
Services (CMS) has spoken: Its Jan. 9 Coverage with Evidence Development (CED)
decision for percutaneous image-guided lumbar decompression (PILD) for lumbar
spinal stenosis (LSS) means that for the foreseeable future, PILD will only be
covered in the context of research studies.
Services (CMS) has spoken: Its Jan. 9 Coverage with Evidence Development (CED)
decision for percutaneous image-guided lumbar decompression (PILD) for lumbar
spinal stenosis (LSS) means that for the foreseeable future, PILD will only be
covered in the context of research studies.
The decision stipulates that new, robustly
designed, randomized controlled trials must address whether PILD significantly
improves function and/or quality of life and reduces pain compared with other
treatments, and also whether it positively affects the overall management and
clinical design making for patients with LSS.
designed, randomized controlled trials must address whether PILD significantly
improves function and/or quality of life and reduces pain compared with other
treatments, and also whether it positively affects the overall management and
clinical design making for patients with LSS.
“We recognize that LSS is a real and
important source of pain and functional limitation for patients, and that the
development of effective minimally invasive procedures could have a potential
place in the treatment armamentarium,” an individual who asked to be identified
as a CMS official told Pain Medicine News.
important source of pain and functional limitation for patients, and that the
development of effective minimally invasive procedures could have a potential
place in the treatment armamentarium,” an individual who asked to be identified
as a CMS official told Pain Medicine News.
No comments:
Post a Comment